… Algorithm for treating the patient with acquired haemophilia. Guidelines to be followed for
the treatment of patients with acquired haemophilia, from the viewpoint of coagulation control …

… This review focuses on acquired haemophilia secondary to autoantibodies directed against
FVIII, AHA. With this work, we intend to expose, updated, the cornerstones of the diagnosis …

… Acquired Haemophilia A is a rare acquired bleeding disorder caused by Factor VIII
autoantibodies, which neutralise FVIII activity. These inhibitors differ from alloantibodies against FVIII, …

… Acquired hemophilia A (AHA) is a rare autoimmune disease caused by autoantibodies
inhibiting the function of coagulation factor VIII. It is characterized by spontaneous bleeding in …

… The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a … Treatment
of acquired haemophilia with factor eight inhibitor bypassing activity. Haemophilia 2004; 10: …

… Acquired haemophilia is a bleeding disorder caused by the spontaneous development of …
acquired form of haemophilia A (4), this article provides an overview of acquired haemophilia …

… and treatment of patients with acquired hemophilia A. … The treatment of bleeding in acquired
haemophilia with recombinant … Treatment of acquired haemophilia with factor eight inhibitor …

… before starting the treatment, although it did appear to be useful for preventing joint damage
… or on-demand treatment with FEIBA ® in patients with congenital or acquired haemophilia A, …

… Rates of main sites of bleeding and of those resulting in death or not requiring haemostatic
treatment in patients with acquired haemophilia A, as reported in the largest published series …

… Diagnostic pathway for acquired hemophilia A. The activated … anticoagulant does not
exclude acquired hemophilia A. See … of hemostatic therapy in acquired hemophilia A. rFVIIa, …